Maggie L. Shaw

Cranbury

Senior Editor at MJH Life Sciences

Editor

Featured in: Favicon

mjhlifesciences.com Favicon

newsbreak.com Favicon

ajmc.com

contemporaryobgyn.net Favicon

dermatologytimes.com Favicon

contemporarypediatrics.com Favicon

managedhealthcareexecutive.com Favicon

drugtopics.com Favicon

ophthalmologytimes.com Favicon

centerforbiosimilars.com + 3 more

Articles

COA 2025: Insight, Innovation, and Independent Strength

1 week ago | ajmc.com | Maggie L. Shaw

The dual goals of the 2025 Community Oncology Conference, hosted by the Community Oncology Alliance (COA), united advocacy and empowerment in a high-impact, 2-day meeting in Orlando on April 29 and 30. With 36 sessions spanning 4 tracks and general presentations, the agenda featured 93 expert speakers committed to empowering patients and providers with the latest insights to improve community oncology care.
Community Oncology Reacts to Trump's Drug Pricing Executive Order

1 week ago | ajmc.com | Maggie L. Shaw

The original plan for the session, “The Impact of Politics and Policy on Community Oncology,” a panel discussion at the 2025 Community Oncology Conference from the Community Oncology Alliance (COA), was for the assembled experts, moderated by Ted Okon, MBA, executive director of COA, to discuss the recent upheaval in Washington, DC—in particular, the personnel changes and legislative issues. However, an executive order signed on Tuesday, May 15, necessitated a change in plans.
Keep Patients at the Center of Clinical Research

2 weeks ago | ajmc.com | Maggie L. Shaw

“The goal, there’s only 1 goal: for all patients to have access to novel therapies, whether they are in rural or urban locations,” emphasized M. Bilal Abid, MD, MS, FACP, MRCP, FRCP, UTHealth Houston McGovern School of Medicine, a panelist for the discussion, “Growing Clinical Trial Infrastructure & Access in Community Oncology” at the 2025 Community Oncology Conference from the Community Oncology Alliance.
Advancing the Art of Medicine Through Partnership

2 weeks ago | ajmc.com | Maggie L. Shaw

A tale of 2 partnerships kicked off day 1 of the 2025 Community Oncology Conference from the Community Oncology Alliance when oncology leaders from hospital- and independent community-based practices came together to extol the benefits of collaboration in cancer care, in a panel discussion moderated by conference co-chair Moshe Chasky, MD, FACP, Alliance Cancer Specialists.
Access to Semaglutide, Tirzepatide for Obesity Not Equal for All

2 weeks ago | ajmc.com | Maggie L. Shaw

Significant disparities and low prescribing rates of semaglutide and tirzepatide for obesity from 2021 through 2024 highlight that there may be potential links to the social factors of race, ethnicity, social vulnerability, urbanicity, and underutilization that demand careful monitoring of not only evolving prescribing practices for these medications but also potential contributions from policy and reimbursement strategies.
Health Gains From US Smoking Decline Fall Short of Expectations

2 weeks ago | ajmc.com | Maggie L. Shaw

The gap in cigarette smoking prevalence between high- and low-prevalence states is expected to close somewhat in the next 10 years, but not the health consequences from smoking, according to findings from US Tobacco Use Supplement to the Current Population Surveys (TUS-CPS), which were repeated from 1992 to 2022.
Fatigue, Quality of Life Improve With Rusfertide: Andrew Kuykendall, MD

2 weeks ago | ajmc.com | Maggie L. Shaw |Andrew Kuykendall

Bringing this interview with Andrew Kuykendall, MD, clinical researcher at Moffitt Cancer Center, to a close, he addresses safety concerns that have been linked to the injectable hepcidin mimetic rusfertide (Takeda) and its overall impact on patient quality of life. Rusfertide is under investigation for treatment of polycythemia vera, a myeloproliferative neoplasm, in the ongoing phase 3 VERIFY trial (NCT05210790), on which Kuykendall is an investigator.
No Definitive Link Found Between Female Infertility and Gynecological Cancer

2 weeks ago | ajmc.com | Maggie L. Shaw

Following their investigation of potential associations between female infertility and several types of gynecological cancer—ovarian, endometrial, cervical, and breast—study authors have found a small potential link between infertility and breast cancer, but not infertility and gynecological cancer.
Early Diagnosis Vital to Myasthenia Gravis Treatment: Richard J. Nowak, MD, MS

2 weeks ago | ajmc.com | Maggie L. Shaw |Richard J. Nowak

Myasthenia gravis is an autoimmune disorder that affects the neuromuscular junction; it cannot be entirely prevented. However, patients do often have symptoms in common that appear frequently before diagnosis. In part 2 of this interview with The American Journal of Managed Care®, Richard J.
Discussing Tirzepatide’s Rise in Diabetes, Obesity Care: Jaime Almandoz, MD, MBA

3 weeks ago | ajmc.com | Maggie L. Shaw |Jaime P. Almandoz

Tirzepatide was first approved for use in the US in May 2022, when it received an indication for adult patients with type 2 diabetes.1 Indications for chronic weight management and sleep apnea quickly followed over the next 2-plus years.2,3 The dual glucagon-like peptide-1 receptor agonist and glucose-dependent insulinotropic polypeptide receptor agonist has been praised for its safety and efficacy,4,5 while also being called out for its cost.6,7 A recent article published in Annals of...